The most commonly recommended drug regimens include acetylsalicylic acid (aspirin), 50 325 mg daily (Albers et al., 1999; Wolf et al., 1999); ticlopidine (Ticlid), 250 mg twice daily (Albers ...

For decades, taking low-dose aspirin (81 mg) every day was widely recommended ... Yet 57 percent of people ages 50 to 80 who regularly take low-dose aspirin probably won’t benefit from it ...

An open-label clinical trial was conducted to compare the effects of aspirin 50 mg/day plus ticlopidine 200 mg/day, aspirin 50 mg/day plus dipyridamole 150 mg/day, and each agent as monotherapy ...

Daily aspirin use after standard adjuvant therapy did not improve DFS for patients with colorectal cancer, according to ...

Patients with treated, PI3K-mutated early CRC had a 50-60% lower risk of recurrence at 3 years if they received 160 mg of aspirin daily. The benefit occurred in patients with PIK3CA exon 9/20 ...

In this video, Michael Cecchini, MD, discussed data from the ALASCCA trial, which followed patients with colorectal cancer who were treated with a large dose of aspirin.

Nearly half of survey respondents (48%) incorrectly said that the benefits of taking low-dose aspirin daily to lower one’s odds of having a stroke or heart attack outweigh the risks, according ...